Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells

Neoplasia

Volumn 9, Issue 3, 2007, Pages 184-191

  Qiao, Jingbo ^a   Kang, Jung Hee ^a   Cree, Jeremy ^a   Evers, B Mark ^a,b   Chung, Dai H ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Angiogenesis; Ets1; GRP; IL 8; Neuroblastoma

Indexed keywords

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; INTERLEUKIN 8; LUCIFERASE; ONCOPROTEIN; TRANSCRIPTION FACTOR ELK 1;

ANGIOGENESIS; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; NEUROBLASTOMA CELL; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 33947404769     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06841     Document Type: Article

References (32)

1. Shusterman S and Maris JM (2005). Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Cancer Lett 228, 171-179.
2. Ribatti D, Marimpietri D, Pastorino F, Brignole C, Nico B, Vacca A, and Ponzoni M (2004). Angiogenesis in neuroblastoma. Ann NY Acad Sci 1028, 133-142.
3. Ribatti D and Ponzoni M (2005). Antiangiogenic strategies in neuroblastoma. Cancer Treat Rev 31, 27-34.
4. Ribatti D, Vacca A, Nico B, De Falco G, Giuseppe Montaldo P, and Ponzoni M (2002). Angiogenesis and anti-angiogenesis in neuroblastoma. Eur J Cancer 38, 750-757.
5. Maris JM and Matthay KK (1999). Molecular biology of neuroblastoma. J Clin Oncol 17, 2264-2279.
6. Kim S, Hu W, Kelly DR, Hellmich MR, Evers BM, and Chung DH (2002). Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 235, 621-629 (discussion, 629-630).
7. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, and Himelstein BP (2000). High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6, 1900-1908.
8. Ferrer FA, Pantschenko AG, Miller LJ, Anderson K, Grunnet M, McKenna PH, and Kreutzer D (2000). Angiogenesis and neuroblastomas: interleukin-8 and interleukin-8 receptor expression in human neuroblastoma. J Urol 164, 1016-1020.
9. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, and Strieter RM (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
10. Roebuck KA (1999). Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19, 429-438.
11. Fibbe WE, Pruijt JF, Velders GA, Opdenakker G, van Kooyk Y, Figdor CG, and Willemze R (1999). Biology of IL-8-induced stem cell mobilization. Ann NY Acad Sci 872, 71-82.
12. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H, Resch K, and Kracht M (2005). MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 280, 9706-9718.
13. Hedvat CV, Yao J, Sokolic RA, and Nimer SD (2004). Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 279, 6395-6400.
14. Graves BJ and Petersen JM (1998). Specificity within the ets family of transcription factors. Adv Cancer Res 75, 1-55.
15. Behrens P, Rothe M, Wellmann A, Krischler J, and Wernert N (2001). The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194, 43-50.
16. Nakayama T, Ito M, Ohtsuru A, Naito S, and Sekine I (2001). Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol 14, 415-422.
17. Lelievre E, Lionneton F, Soncin F, and Vandenbunder B (2001). The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol 33, 391-407.
18. Shimada H (1992). Neuroblastoma. Pathology and biology. Acta Pathol Jpn 42, 229-241.
19. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, and Ostrowski MC (1996). Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 16, 538-547.
20. Qiao J, Kang J, Cree J, Evers BM, and Chung DH (2005). Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Ann Surg 241, 684-691 (discussion, 691-682).
21. Facchetti P, Prigione I, Ghiotto F, Tasso P, Garaventa A, and Pistoia V (1996). Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma. Cancer Immunol Immunother 42, 170-178.
22. Ren Y, Chan HM, Li Z, Lin C, Nicholls J, Chen CF, Lee PY, Lui V, Bacher M, and Tam PK (2004). Upregulation of macrophage migration inhibitory factor contributes to induced N-myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23, 4146-4154.
23. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, et al. (2005). Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11, 992-997.
24. Xu L, Pathak PS, and Fukumura D (2004). Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3′-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clin Cancer Res 10, 701-707.
25. Dittmer J (2003). The biology of the Ets1 proto-oncogene. Mol Cancer 2, 29.
26. Fujimoto J, Aoki I, Toyoki H, Khatun S, and Tamaya T (2002). Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers. Ann Oncol 13, 1605-1611.
27. 3. J Cell Physiol 178, 121-132.
28. Xiao D, Qu X, and Weber HC (2002). GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells. Regul Pept 109, 141-148.
29. Thomas SM, Grandis JR, Wentzel AL, Gooding WE, Lui VW, and Siegfried JM (2005). Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. Neoplasia 7, 426-431.
30. Levine L, Lucci JA III, Pazdrak B, Cheng JZ, Guo YS, Townsend CM Jr, and Hellmich MR (2003). Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res 63, 3495-3502.
31. Meloni F, Ballabio P, Bianchi L, Mangiarotti P, Grassi G, Bignamini A, and Grassi GG (1996). Bombesin enhances monocyte and macrophage activities: possible role in the modulation of local pulmonary defenses in chronic bronchitis. Respiration 63, 28-34.
32. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, and Reich R (2003). Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev 22, 103-115.